Table 1. Overview of CPTI roles in cancer biology.
CPTI isoform | Cancer type | Significance | Reference |
---|---|---|---|
CPTIA | Prostate cancer | Upregulated expression; its inhibition has antitumor actions | 25, 41, 50 |
Burkitt's lymphoma | Upregulated expression | 28 | |
Glioblastoma | Upregulated expression | 29, 30 | |
Lymphocytic leukemia | Its inhibition has antitumor actions; contributes to cancer chemoresistance | 7, 35, 42 | |
Breast cancer | Upregulated expression; its inhibition has antitumor actions; acts as a new role in the histonic acetylation level of tumor | 37, 52, 53, 54, 55, 86 | |
Gastric cancer | Oleic acid activates its expression | 55 | |
Ovarian cancer | Upregulated expression | 56, 57 | |
Alveolar rhabdomyosarcoma | Contributes to cancer cell motility | 74 | |
Teratocarcinoma | Transcriptional regulation of it by RXR-NR4A receptor | 81 | |
Endothelial cells | Upregulated expression; contributes to tumor neovascularization | 98, 99 | |
CPTIC | Lung cancer | Upregulated expression contributes to cancer chemoresistance | 18 |
Colon | Its inhibition has antitumor actions | 18 | |
Breast | Upregulated expression | 18, 62 | |
Glioblastoma | Upregulated expression | 29, 59 | |
CPTI (unspecified isoform) | Hepatoma | Upregulated expression | 58, 60 |
Acute myeloid leukemia | Its inhibition has antitumor actions | 63 | |
Diffuse large B-cell lymphoma | Upregulated expression | 26, 27 | |
Myeloma | Its inhibition has antitumor actions | 51 | |
Lung cancer | Contributes to cancer chemoresistance | 34 |
Abbreviation: CPTI, carnitine palmitoyltransferase I